22.01.2015 Views

6th International Workshop on Breast Densitometry and Breast ...

6th International Workshop on Breast Densitometry and Breast ...

6th International Workshop on Breast Densitometry and Breast ...

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

6 th <str<strong>on</strong>g>Internati<strong>on</strong>al</str<strong>on</strong>g> <str<strong>on</strong>g>Workshop</str<strong>on</strong>g> <strong>on</strong> <strong>Breast</strong> <strong>Densitometry</strong><br />

<strong>and</strong> <strong>Breast</strong> Cancer Risk Assessment<br />

heterogeneously dense <strong>and</strong> dense breast tissue, <strong>and</strong> to formulate recommendati<strong>on</strong>s when no science was<br />

available to guide policy.<br />

Materials <strong>and</strong> Methods: The CBDIG task was to review existing scientific literature to provide<br />

evidence-based recommendati<strong>on</strong>s for guiding health care providers <strong>and</strong> women regarding supplemental<br />

screening after notificati<strong>on</strong>, <strong>and</strong> to formulate recommendati<strong>on</strong>s when no science was available to guide<br />

policy. Each facility then developed their own policy to resp<strong>on</strong>d to SB 1538, which was implemented in<br />

California <strong>on</strong> April 1, 2013.<br />

Results: After breast density notificati<strong>on</strong>, Figure 2: NCCN, ACS <strong>and</strong> ACR Guidelines CBDIG<br />

recommended women <strong>and</strong> health care for <strong>Breast</strong> Cancer Screening after Normal<br />

providers to c<strong>on</strong>sider supplemental breast Screening Mammography<br />

cancer<br />

screening based <strong>on</strong> breast cancer risk<br />

assessment (6) using family history models (7,8)<br />

based <strong>on</strong> recommendati<strong>on</strong>s from nati<strong>on</strong>ally<br />

High risk (> 20% lifetime) – MRI*<br />

Intermediate risk (15-20% lifetime ) – possible MRI**<br />

recognized guidelines (7,8,9) (Figure 2). Average Risk (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!